CII (CII) Stock Price & Analysis
CII (CII) rose 0.04% to USD 24.21 as of June 10, 2026 at 02:22 UTC, according to Nexqual real-time market data.
CII last closed at USD 24.2; the session ranged USD 23.85–24.55 on volume of 67,908 shares. Market capitalization is $992.21M, with a 52-week range of USD 20.27–26.17 (NYQ). Source: Nexqual, June 10, 2026 at 02:22 UTC.
Key Statistics (as of June 10, 2026 at 02:22 UTC)
| Price | USD 24.21 |
|---|---|
| Change | ▲ 0.04% (up) |
| Previous Close | USD 24.2 |
| Open | USD 24.35 |
| Day Range | USD 23.85 – 24.55 |
| 52-Week Range | USD 20.27 – 26.17 |
| Volume | 67,908 shares |
| Market Cap | $992.21M |
| Exchange | NYQ |
Technical Analysis (CII)
Nexqual's technical model rates CII "BUY" based on 4 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 02:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 42.95 (neutral) |
| vs SMA50 | Above (USD 23.95) |
| MACD | 0.16 (positive) |
Analyst Ratings (CII)
Wall Street analysts rate CII "None", per Nexqual as of June 10, 2026 at 02:22 UTC.
| Consensus Rating | None |
|---|---|
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (CII)
Source: Nexqual, June 10, 2026 at 02:22 UTC.
Financials & Fundamentals (CII)
| Total Revenue | $8.18M |
|---|---|
| Revenue Growth (YoY) | -4.50% |
| Gross Margin | +100.00% |
| Operating Margin | +4.70% |
| Profit Margin | +2542.45% |
| ROE | +22.76% |
| Debt / Equity | 0 |
| Current Ratio | 0.01 |
| Total Cash | $664 |
| Total Debt | $14,001 |
| Free Cash Flow | $80.46M |
Source: Nexqual, June 10, 2026 at 02:22 UTC.
Financial Health Score (CII)
Nexqual rates CII's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:22 UTC.
| Growth | Weak — Revenue -5% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $664 cash, no debt |
| Cash Flow | Strong — FCF $80M, 984% margin |
| Efficiency | Strong — ROE 23%, ROA -0.0% |
Ownership (CII)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +24.38% |
| Shares Outstanding | 40.98M |
| Short % of Float | +1.42% |
Source: Nexqual, June 10, 2026 at 02:22 UTC.
Major Backers & Investors (CII)
Notable institutional backers of CII include Raymond James Financial, Inc., Morgan Stanley, Wells Fargo & Company, according to Nexqual as of June 10, 2026 at 02:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Raymond James Financial, Inc. | 2.53% |
| Morgan Stanley | 1.78% |
| Wells Fargo & Company | 1.67% |
| Invesco | 1.61% |
| LPL Financial LLC | 1.31% |
| Osaic Holdings Inc. | 1.18% |
| Bank of America Corporation | 1.13% |
| Advisors Asset Management, Inc. | 1.07% |
Source: Nexqual, June 10, 2026 at 02:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDJ | Blackrock Enhanced Equity Divid | USD 9.22 | ▲ 0.77% |
| BOE | Blackrock Enhanced Global Divid | USD 11.81 | ▲ 0.77% |
| BGY | Blackrock Enhanced Internationa | USD 5.66 | ▲ 0.18% |
| ETY | Eaton Vance Tax-Managed Diversi | USD 14.5 | ▲ 0.14% |
| BME | Blackrock Health Sciences Trust | USD 40.48 | ▲ 1.35% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:22 UTC. This page is informational and not investment advice.